BC Week In Review | Oct 13, 2014
Clinical News

Xeglyze: Phase III data

Data from a pair of identical, double-blind, U.S. Phase III trials in a total of 704 patients aged 6 months and older with an active head lice infestation showed that a single topical treatment of...
BC Week In Review | Nov 11, 2013
Financial News

Hatchtech completes venture financing

Hatchtech Pty. Ltd. , Melbourne, Australia   Business: Infectious, Agbio/Environmental   Date completed: 10/31/13   Type: Venture financing   Raised: A$12.6 million ($11.9 million)   Investors: OneVentures; University of Melbourne Endowment Trust; Queensland Biotechnology Fund; UniSeed;...
BC Week In Review | Nov 11, 2013
Company News

Hatchtech board of directors update

Hatchtech Pty. Ltd. , Melbourne, Australia   Business: Infectious, Agbio/Environmental   Appointed: CEO Hugh Alsop  ...
BC Week In Review | Mar 18, 2013
Company News

Hatchtech management update

Hatchtech Pty. Ltd. , Melbourne, Australia   Business: Infectious, Agbio/Environmental   Hired: Hugh Alsop as CEO, formerly VP of operations and business development at Phosphagenics Ltd. ; he replaces Ross Macdonald, who remains a director  ...
BC Week In Review | Dec 17, 2012
Financial News

Hatchtech completes venture financing

Hatchtech Pty. Ltd. , Melbourne, Australia   Business: Infectious, Agbio/Environmental   Date completed: 12/12/12   Type: Venture financing   Raised: A$6 million ($6.3 million)   Investor: OneVentures  ...
BC Week In Review | May 7, 2012
Company News

Hatchtech management update

Hatchtech Pty. Ltd. , Melbourne, Australia   Business: Infectious, Agbio/Environmental   Hired: Ross Macdonald, non-executive director, as CEO, formerly VP of business development for North America and South Pacific at Sinclair Pharmaceuticals Ltd., now a subsidiary...
BC Week In Review | May 7, 2012
Financial News

Hatchtech financial update

Hatchtech raised an additional A$1.5 million ($1.6 million) in a venture round, bringing the total raised in the round to A$7.8 million ($7.8 million). Existing investors participated. The company raised A$6.3 million ($6.3 million) in...
BC Week In Review | Dec 5, 2011
Company News

Hatchtech management update

Hatchtech Pty. Ltd. , Parksville, Australia   Business: Infectious, Agbio/Environmental   Hired: Timothy Waugh as CEO, formerly a divisional VP at Roche  ...
BC Week In Review | May 9, 2011
Clinical News

DeOvo: Phase IIb started

Hatchtech began a double-blind, placebo-controlled, U.S. Phase IIb trial to evaluate high- and low-dose topical DeOvo in 132 healthy subjects with head lice infestation. Hatchtech Pty. Ltd. , Parksville, Australia   Product: DeOvo   Business: Infectious...
BC Week In Review | Nov 1, 2010
Financial News

Hatchtech completes venture financing

Hatchtech Pty. Ltd. , Parksville, Australia   Business: Infectious, Agbio/Environmental   Date completed: 10/26/10   Type: Venture financing   Raised: A$6.3 million (US$6.3 million)   Investors: OneVentures; University of Melbourne Endowment Trust; GBS Venture Partners; UniSeed;...
Items per page:
1 - 10 of 13
BC Week In Review | Oct 13, 2014
Clinical News

Xeglyze: Phase III data

Data from a pair of identical, double-blind, U.S. Phase III trials in a total of 704 patients aged 6 months and older with an active head lice infestation showed that a single topical treatment of...
BC Week In Review | Nov 11, 2013
Financial News

Hatchtech completes venture financing

Hatchtech Pty. Ltd. , Melbourne, Australia   Business: Infectious, Agbio/Environmental   Date completed: 10/31/13   Type: Venture financing   Raised: A$12.6 million ($11.9 million)   Investors: OneVentures; University of Melbourne Endowment Trust; Queensland Biotechnology Fund; UniSeed;...
BC Week In Review | Nov 11, 2013
Company News

Hatchtech board of directors update

Hatchtech Pty. Ltd. , Melbourne, Australia   Business: Infectious, Agbio/Environmental   Appointed: CEO Hugh Alsop  ...
BC Week In Review | Mar 18, 2013
Company News

Hatchtech management update

Hatchtech Pty. Ltd. , Melbourne, Australia   Business: Infectious, Agbio/Environmental   Hired: Hugh Alsop as CEO, formerly VP of operations and business development at Phosphagenics Ltd. ; he replaces Ross Macdonald, who remains a director  ...
BC Week In Review | Dec 17, 2012
Financial News

Hatchtech completes venture financing

Hatchtech Pty. Ltd. , Melbourne, Australia   Business: Infectious, Agbio/Environmental   Date completed: 12/12/12   Type: Venture financing   Raised: A$6 million ($6.3 million)   Investor: OneVentures  ...
BC Week In Review | May 7, 2012
Company News

Hatchtech management update

Hatchtech Pty. Ltd. , Melbourne, Australia   Business: Infectious, Agbio/Environmental   Hired: Ross Macdonald, non-executive director, as CEO, formerly VP of business development for North America and South Pacific at Sinclair Pharmaceuticals Ltd., now a subsidiary...
BC Week In Review | May 7, 2012
Financial News

Hatchtech financial update

Hatchtech raised an additional A$1.5 million ($1.6 million) in a venture round, bringing the total raised in the round to A$7.8 million ($7.8 million). Existing investors participated. The company raised A$6.3 million ($6.3 million) in...
BC Week In Review | Dec 5, 2011
Company News

Hatchtech management update

Hatchtech Pty. Ltd. , Parksville, Australia   Business: Infectious, Agbio/Environmental   Hired: Timothy Waugh as CEO, formerly a divisional VP at Roche  ...
BC Week In Review | May 9, 2011
Clinical News

DeOvo: Phase IIb started

Hatchtech began a double-blind, placebo-controlled, U.S. Phase IIb trial to evaluate high- and low-dose topical DeOvo in 132 healthy subjects with head lice infestation. Hatchtech Pty. Ltd. , Parksville, Australia   Product: DeOvo   Business: Infectious...
BC Week In Review | Nov 1, 2010
Financial News

Hatchtech completes venture financing

Hatchtech Pty. Ltd. , Parksville, Australia   Business: Infectious, Agbio/Environmental   Date completed: 10/26/10   Type: Venture financing   Raised: A$6.3 million (US$6.3 million)   Investors: OneVentures; University of Melbourne Endowment Trust; GBS Venture Partners; UniSeed;...
Items per page:
1 - 10 of 13